Anti-Neurotrophin 4 antibodies are used for the immunodetection of the protein encoded by the NTF4 gene. In humans, the canonical protein has a reported length of 210 amino acid residues and a mass of 22.4 kDa. It is known to be a secreted protein. It is reported to be highly expressed in prostate, lower levels in thymus, placenta, and skeletal muscle. A member of the NGF-beta protein family, it is known to be involved with epidermis development and the regulation of apoptosis. Post-translational modifications have been described, including glycosylation. The gene encoding this protein is implicated in Glaucoma. Other names for this target antigen include GLC1O, NT-4, NT-4/5, NT-5, NT4, NT5, NTF5, and GLC10. Gene orthologs have been identified in the mouse, rat, bovine, frog and chimpanzee species. A number of Neurotrophin 4 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.